In Côte d’Ivoire, those who are educated about HIV-prevention medication are more likely to want to take a daily dose of pre-exposure prophylaxis (or PrEP).
Under the CCP-led Breakthrough ACTION project, more people are learning their HIV status and being treated with highly effective medicines.
Before the COVID-19 pandemic, the most common way to get antiretroviral therapy in Côte d’Ivoire was to go to the health center every month. Now, CCP is bringing it directly to the homes of people living with HIV.
New CCP-led research suggests that a program devoted to encouraging men to be tested for HIV successfully pivoted to include support for men who test positive and ushering them into treatment.
Viewers across Africa can now watch CCP’s highly-rated, Peabody Award-winning TV series about HIV on Netflix.
We look back at some of the top stories we told about CCP in 2019, and look forward to sharing more of CCP’s great work in the new year.
CCP’s team in Mozambique tries a new approach to getting men tested for HIV, one learned from the success of a CCP program in Cote d’Ivoire.
The primary barrier to getting men in Cote d’Ivoire tested for HIV is fear – fear not of the disease itself, but of the social and economic consequences that a positive diagnosis could bring, new CCP research suggests.
Research suggests that comprehensively considering how HIV threatens many aspects of men’s lives – instead of just their health – could help more men initiate antiretroviral therapy (ART).
CCP is engaging with influential local leaders to help them collect data to make decisions that could reduce the nation’s high HIV infection rate.
Receive the latest news and updates, tools, events and job postings in your inbox every month
